MAYA CLINICALS DRUG DEVELOPMENT PRIVATE LIMITED

Hyderabad-based Maya Clinicals Drug Development has generated a revenue of Rs 1 crore during the FY19-20. The company is focused on working with bio-pharma startups and pharma companies in a unique and flexible co-development fashion to accelerate pre-clinical and clinical projects. Maya Clinicals has been able to greatly increase the chance of success for its US and European customers’ development programmes by utilising the greater manpower and expertise available in India and South East Asia and with focused US expertise and management. It is deeply focused on clinical trials and related logistics and is based on an operational platform with all the crucial pieces required for success.